Long-Term Assets: The sum of all assets classified as non-current.
Emergent Biosolutions Inc. (EBS) had Long-Term Assets of $791.00M for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$194.70M |
|
$-31.30M |
|
$118.00M |
|
$76.70M |
|
$204.20M |
|
$-9.50M |
|
$-18.10M |
|
$-27.60M |
|
$-27.60M |
|
$-31.30M |
|
$-31.30M |
|
$-31.30M |
|
$-31.30M |
|
$-9.50M |
|
$18.70M |
|
53.00M |
|
53.00M |
|
$-0.55 |
|
$-0.45 |
|
| Balance Sheet Financials | |
$598.70M |
|
$270.60M |
|
|
Long-Term Assets |
$791.00M |
$1.39B |
|
$162.40M |
|
$663.70M |
|
$744.50M |
|
$906.90M |
|
$482.80M |
|
$-18.70M |
|
$482.80M |
|
54.30M |
|
| Cash Flow Statement Financials | |
$58.70M |
|
$125.20M |
|
$-190.00M |
|
$111.70M |
|
$105.60M |
|
$-6.10M |
|
$18.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.69 |
|
-- |
|
-- |
|
0.58 |
|
1.37 |
|
39.39% |
|
-4.88% |
|
-4.88% |
|
-- |
|
-14.18% |
|
-16.08% |
|
$43.70M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.38 |
|
1.26 |
|
71.42 |
|
-6.48% |
|
167.38% |
|
-2.25% |
|
-2.73% |
|
$8.89 |
|
$0.82 |
|
$1.11 |
|